上海复星医药(集团)股份有限公司 关于召开2025年第二次临时股东会的通知

Group 1 - The company will hold its second extraordinary general meeting of shareholders in 2025 on December 2 at 13:30 [2][3] - The meeting will be conducted using a combination of on-site and online voting methods [3][4] - A-share shareholders can vote through the Shanghai Stock Exchange's online voting system during specified trading hours on the meeting day [4][8] Group 2 - The meeting will take place at the Shanghai Tianxi Jiafu Putike Hotel, located at 358 Hongxu Road, Shanghai [3] - A-share shareholders must register for the meeting either online or on-site, with specific requirements for both individual and institutional shareholders [15][17] - H-share shareholders are advised to refer to the company's announcement on the Hong Kong Stock Exchange for registration details [12][19] Group 3 - The company announced a pledge and release of shares by its controlling shareholder, Fosun High Technology, with a total of 961,424,455 shares held as of November 6, 2025, accounting for 36.00% of the total shares [27][28] - After the pledge and release, the remaining pledged shares amount to 546,925,000 shares, representing 20.48% of the total shares [27][30] - The controlling shareholder confirmed that the pledged shares are not used for major asset restructuring or performance compensation guarantees [29][32]